Pidotimod: An Immunity Booster

Authors

  • Shubhrica Assistant Professor Dept. of Ophthalmology, NC Medical College and Hospital, Israna (Panipat), Haryana
  • Jyoti Yadav † Senior Professor and Head, Dept. of Physiology, Pt. BD Sharma PGIMS, Rohtak, Haryana

Keywords:

Immunomodulators, immunity, immunoglobulin

Abstract

Pidotimod is a synthetic dipeptide, which has immunomodulatory property. It is used in recurrent upper respiratory tract infections, where there is nonspecific immune deficiency, especially in children who are more prone to recurrent respiratory infections. This article discusses its structure, pharmacokinetics including mechanism of action and clinical uses. A brief review of literature has been carried out. Possible future application is suggested.

Downloads

Published

2022-11-18

Issue

Vol. 33 No. 6 (2022)

Section

New Drug

License

All open access articles published in IJCP are distributed under the terms of the CC BY-NC 4.0 license (Creative Commons Attribution-Non-Commercial 4.0 International Public License). This license permits unrestricted use, distribution, and reproduction of the articles in any medium for non-commercial purposes, provided that:  The original authorship is properly and fully attributed.   The IJCP is cited as the original place of publication with correct citation details.  If an original work is reproduced or disseminated in part or as a derivative work, this must be clearly indicated.  No articles are reproduced for commercial use without prior consent from the IJCP. All licensing requests and permissions for commercial use will be managed by the Publisher. 

How to Cite

Pidotimod: An Immunity Booster. (2022). Indian Journal Of Clinical Practice, 33(6), 18-20. https://ojs.ijcp.in/index.php/IJCP/article/view/271